Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
F. Lordick
(1)
,
F. Carneiro
(2)
,
S. Cascinu
,
T. Fleitas
,
K. Haustermans
(3)
,
G. Piessen
(4, 5)
,
A. Vogel
(6, 7)
,
E.C. Smyth
1
Leipzig University / Universität Leipzig
2 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and Medical Fa
3 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
4 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
5 CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277
6 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
7 MEPHI - Microbes évolution phylogénie et infections
2 Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP) and Medical Fa
3 KU Leuven - Catholic University of Leuven = Katholieke Universiteit Leuven
4 CHRU Lille - Centre Hospitalier Régional Universitaire [CHU Lille]
5 CANTHER - Cancer Heterogeneity, Plasticity and Resistance to Therapies - UMR 9020 - U 1277
6 IHU Marseille - Institut Hospitalier Universitaire Méditerranée Infection
7 MEPHI - Microbes évolution phylogénie et infections